"Major Histocompatibility Complex: Structure, Function & Slideshare"

The Major Histocompatibility Complex (MHC) is a vital component of the adaptive immune system, playing a crucial role in antigen presentation and self/non-self discrimination. This article delves into the structure and function of the MHC, with a focus on the human leukocyte antigen (HLA) system, using insights from SlideShare presentations and other reliable sources.

Understanding the Major Histocompatibility Complex

The MHC is a set of genes located on chromosome 6 in humans, encoding for cell surface glycoproteins that present peptide antigens to T cells. It is divided into three regions: Class I, Class II, and Class III, each with distinct functions and gene products.

MHC Class I: Presentation of Intracellular Antigens

MHC Class I molecules are expressed on all nucleated cells and present intracellular antigens, such as viral peptides or cancerous cells, to CD8+ T cells (cytotoxic T cells). The MHC Class I heavy chain is encoded by the HLA-A, HLA-B, and HLA-C genes, while the light chain is the beta-2-microglobulin (β2m) protein.

• Antigen processing: Intracellular antigens are processed in the cytosol by the proteasome and transported to the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP).
• Peptide binding: In the ER, peptides bind to the MHC Class I heavy chain and β2m to form a stable complex.
• Transport and presentation: The MHC Class I-peptide complex is then transported to the cell surface for recognition by CD8+ T cells.

MHC Class II: Presentation of Extracellular Antigens

MHC Class II molecules are expressed on professional antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells. They present extracellular antigens, like bacterial and fungal peptides, to CD4+ T cells (helper T cells). The MHC Class II molecule consists of an alpha and a beta chain, encoded by the HLA-DP, HLA-DQ, and HLA-DR genes.

• Antigen processing: Extracellular antigens are taken up by APCs, processed in the lysosome, and then transported to the MHC Class II compartment (MIIC) by the invariant chain (Ii).
• Peptide binding: In the MIIC, peptides replace the Ii and bind to the MHC Class II alpha and beta chains to form a stable complex.
• Transport and presentation: The MHC Class II-peptide complex is then transported to the cell surface for recognition by CD4+ T cells.

The Human Leukocyte Antigen (HLA) System

The HLA system is the human version of the MHC, playing a critical role in organ transplantation compatibility and disease association studies. It is the most polymorphic gene system in humans, with over 12,000 alleles identified to date.

HLA Polymorphism and Disease Association

The extensive polymorphism of the HLA system allows for a diverse repertoire of T cell receptors, enabling the immune system to recognize and respond to a wide range of pathogens. However, this polymorphism also makes the HLA system a target for autoimmune and infectious diseases. Many diseases, such as celiac disease, rheumatoid arthritis, and HIV/AIDS, have been associated with specific HLA alleles.

HLA and Organ Transplantation

HLA matching is crucial for successful organ transplantation. The closer the match between the donor and recipient's HLA alleles, the lower the risk of graft rejection. HLA typing is performed using molecular techniques, such as polymerase chain reaction (PCR) and sequencing, to determine the HLA alleles present in an individual.

Conclusion and Future Directions

The MHC, particularly the HLA system, is a complex and vital component of the immune system. Understanding its structure and function has led to significant advances in immunology, transplantation medicine, and disease association studies. However, there is still much to learn about the MHC, and ongoing research continues to uncover new insights into its role in health and disease.